Ketamine and DMT both produce profoundly altered states of consciousness, but through entirely different mechanisms and with radically different characters. Ketamine is a dissociative anesthetic — an NMDA receptor antagonist that separates consciousness from the body, producing dreamlike states, analgesia, and at higher doses, the famous "K-hole." DMT (N,N-Dimethyltryptamine) is an intensely powerful psychedelic tryptamine — a 5-HT2A agonist that, when smoked or vaporized, produces an overwhelming 5–15 minute experience often described as being "shot out of a cannon into another dimension." They are compared less because they are similar and more because both sit at the extreme end of altered states — each capable of producing experiences that users describe as among the most profound of their lives.
| Effects | 62 documented | 51 documented |
Duration could not be more different. Smoked/vaporized DMT lasts 5–15 minutes. An intramuscular ketamine experience lasts 45–90 minutes, and oral ketamine can last 1–2 hours. Ayahuasca (oral DMT with an MAOI) lasts 4–6 hours. The brevity of smoked DMT is one of its defining features — it delivers an impossibly intense experience that is over before you've fully processed that it began.
Character of the experience differs fundamentally. DMT produces vivid, detailed, and coherent alternate realities — users report encounters with seemingly autonomous entities, impossible geometric architectures, and experiences of cosmic significance. The visuals are described as "more real than real." Ketamine produces dreamlike dissociation — a floating, detached state where the body falls away and consciousness enters an abstract, often darkened space. The K-hole is more dissolving and amorphous than DMT's hyperreal visions.
Body awareness diverges sharply. Ketamine is an anesthetic — it dulls physical sensation and often makes the body feel distant or nonexistent. DMT leaves body awareness relatively intact (though attention is usually entirely captured by the visual/cognitive experience). Users coming out of a DMT experience are physically functional almost immediately; ketamine requires a longer recovery period.
Medical use gives ketamine a unique position. It is a WHO Essential Medicine used worldwide for anesthesia and, increasingly, for treatment-resistant depression. Ketamine clinics are legal and widespread. DMT has no approved medical use, though research into its therapeutic potential is accelerating.
Safety profile differs importantly. Ketamine carries risks of bladder damage with chronic use, psychological dependence with frequent use, and respiratory depression at very high doses. DMT's primary risk is psychological — the experience can be overwhelming and distressing — but it shows no organ toxicity and minimal physical risk when the set/setting is controlled.
| Level | Dose |
|---|---|
| Threshold | 5 mg |
| Light | 10–30 mg |
| Common | 30–75 mg |
| Strong | 75–150 mg |
| Heavy | 150 mg |
| Level | Dose |
|---|---|
| Threshold | 50 mg |
| Light | 50–100 mg |
| Common | 100–300 mg |
| Strong | 300–450 mg |
| Heavy | 450 mg |
| Level | Dose |
|---|
| Level | Dose |
|---|---|
| Threshold | 4 mg |
| Light | 4–10 mg |
| Common | 10–15 mg |
| Strong | 15–20 mg |
| Heavy | 20 mg |
| Level | Dose |
|---|---|
| Threshold | 2 mg |
| Light | 10–20 mg |
| Common | 20–40 mg |
| Strong | 40–60 mg |
| Heavy | 60 |
Total: 1 hrs – 2 hrs
Total: 15 min – 30 min
No direct interaction data available between these substances. This does not mean the combination is safe.
No dangerous interactions recorded.
Total: 5 min – 20 min